Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-0646
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors ; day:28 ; month:6 ; year:2021 ; pages:1-11
Investigational new drugs ; (28.6.2021), 1-11

Creator
Italiano, Antoine
Miller, Wilson H.
Blay, Jean-Yves
Gietema, Jourik A.
Bang, Yung-Jue
Mileshkin, Linda R.
Hirte, Hal W.
Higgins, Brian
Blotner, Steven
Nichols, Gwen L.
Chen, Lin Chi
Petry, Claire
Yang, Qi Joy
Schmitt, Christophe
Jamois, Candice
Siu, Lillian L.
Contributor
SpringerLink (Online service)

DOI
10.1007/s10637-021-01141-2
URN
urn:nbn:de:101:1-2021101019065588254849
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Italiano, Antoine
  • Miller, Wilson H.
  • Blay, Jean-Yves
  • Gietema, Jourik A.
  • Bang, Yung-Jue
  • Mileshkin, Linda R.
  • Hirte, Hal W.
  • Higgins, Brian
  • Blotner, Steven
  • Nichols, Gwen L.
  • Chen, Lin Chi
  • Petry, Claire
  • Yang, Qi Joy
  • Schmitt, Christophe
  • Jamois, Candice
  • Siu, Lillian L.
  • SpringerLink (Online service)

Other Objects (12)